Good morning and welcome to October. Elizabeth Cooney sitting in for Ed Silverman again today from STAT in Boston, where just the hint of crisp fall air gladdens the hearts of runners and others who wilt in summer heat. But enough with the weather and on with the news:
Endo International, Johnson & Johnson, and other drug makers that face sprawling litigation over the opioid crisis are exploring an unusual way to settle the cases: by participating in Purdue Pharma’s bankruptcy, the Wall Street Journal reports, according to internal documents and a person familiar with the matter. The move, if successful, could bring an end to — or at least dramatically shrink — one of the largest and most complex pieces of litigation the U.S. has ever seen.